Does Oliver Reuss invest in AI startups?

Yes. Artificial Intelligence is one of the sectors on Oliver Reuss's investor profile, together with Digital Health & HealthTech, MedTech & Medical Devices and Biotech & Pharma. The stages on record are seed, Series A and Series B.

Which companies has Oliver Reuss backed?

The record lists 43 deals, including Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and Actym. None of them has a perk listed on AI Perks yet.

What credits can a startup claim before pitching Oliver Reuss?

For a company raising a seed round, AI Perks lists credits such as Amazon Bedrock (up to $200,000), Beefree SDK (up to $10,000), Google Cloud (up to $350,000) and Ansys (up to $15,000), with each program's terms and how to apply.

Does AI Perks publish investor contact details?

No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.

Oliver Reuss

Venture investor in Germany

Invests in AI

AI is one of the sectors on Oliver Reuss's investor profile, next to Digital Health & HealthTech, MedTech & Medical Devices and Biotech & Pharma, at seed, Series A and Series B. The record holds 43 deals, including Aignostics, T3 Pharmaceuticals and Dopavision.

Email Investor

Credits to line up before a seed round

Oliver Reuss backs companies at seed, Series A and Series B. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

Aignostics
T3 Pharmaceuticals
Dopavision
Topas Therapeutics
Actym
eTheRNA immunotherapies
STAT-Dx
Rinri Therapeutics
Rigontec
Hookipa Pharma
Tacalyx
NBE-Therapeutics
Aelin Therapeutics
Okairos
ImCheck Therapeutics
Wellth
T-knife
Brainomix
Acousia Therapeutics
Rgenta Therapeutics
DiogenX
Cardior Pharmaceuticals
C-mo Medical Solutions
Delonix Bioworks
Bodyport
Ruipeng Pet Healthcare
Boehringer Ingelheim
Metabomed
ArmaGen Technologies
Rewind Therapeutics
HepaRegeniX
Perfood
Eyevensys
Promethera Biosciences
Sentien Biotechnologies
Amal Therapeutics
Vira Therapeutics
OncoMyx Therapeutics
GLOX Therapeutics Ltd.
Libra Therapeutics
Abalos Therapeutics
Perfood GmbH
AgomAb Therapeutics

Investment focus

Backs startups in: Artificial Intelligence, Digital Health & HealthTech, MedTech & Medical Devices, Biotech & Pharma
Rounds: Seed, Series A, Series B
Profile: Venture investor
Deals on record: 43
Based in: Germany

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Oliver Reuss invest in AI startups?: Yes. Artificial Intelligence is one of the sectors on Oliver Reuss's investor profile, together with Digital Health & HealthTech, MedTech & Medical Devices and Biotech & Pharma. The stages on record are seed, Series A and Series B.
Which companies has Oliver Reuss backed?: The record lists 43 deals, including Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and Actym. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Oliver Reuss?: For a company raising a seed round, AI Perks lists credits such as Amazon Bedrock (up to $200,000), Beefree SDK (up to $10,000), Google Cloud (up to $350,000) and Ansys (up to $15,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?: No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor
Email Investor
Your full name

Source: public professional information. Is this you? Request removal